Drenth, J.P.H.

patient liver treatment escitalopram study polycystic polycystic liver disease depression placebo transplantation hepatitis c liver transplantation therapy polycystic liver score disease hepatitis survival group center symptom outcome depressive transplant trial side-effects randomised effect baseline university netherland scale aliment pharmacol department history bene ficial effect genotype feeling graft survival ribavirin hepatology radboud university nijmegen graft anxiety hospital complication research prophylactic centre hospitalier universitaire analysis european authors transplant pharmacol 24 weeks escitalopram group signi table publishing result aliment point 1306–1317 concentration follow-up polycystic livers placebo group volume study code episode liver volume blackwell disorder keimpema rating tension development anxiety scale sadness prophylactic treatment research design